Intermediate generalisation (added matter) at the EPO
In this webinar, Partners Michael Stott and Posy Drywood discuss how and why objections over intermediate generalisation arise, the arguments that are most likely to be effective when faced with them, and drafting tips and tricks that can help avoid them altogether.
Watch nowWatch webinar
x
Balancing clinical trial disclosures with sufficiency and inventive step requirements
In this webinar, Partners Stephen Garner and Anna Gregson explore the impact of clinical trials on the assessment of sufficiency and inventive step, while exploring recent EPO case law.
Watch nowWatch webinar
x
Patent drafting for success in Europe
The European Patent Office’s strict approach to the assessment of written basis can be a potential minefield for applicants looking to amend around prior art. Partners Martin MacLean and David Hobson provide their tips and tricks to build into your drafting practice to safeguard against common pitfalls.
Watch nowWatch webinar
x
AI in life sciences – patenting dos and don’ts
In this webinar, Partners Jeremy Smith and Alexander Robinson take a look at the European Patent Office’s approach to the developing field AI in life sciences, including an overview of the fundamentals of AI together with case studies highlighting important issues for life sciences AI inventions in particular.
Watch nowWatch webinar
x
Changes to the EPO Guidelines on description amendments
A new 2021 edition of the EPO Guidelines for Examination will come into effect in March 2021, with significant revisions regarding the requirement to amend the description for conformity with the claims expected. In this webinar, Partners Hazel Ford and Andrew White discuss the potential implications of these changes.
Watch nowWatch webinar
x
Standard Essential Patents in Europe
In this webinar, Mathys & Squire Partners Andreas Wietzke and Andrew White are joined by IP specialist barrister Edward Cronan from Hogarth Chambers to discuss recent Standard Essential Patent (SEP) litigation cases in Europe.
Watch nowWatch webinar
x
Plausibility at the EPO – exploring the legacy of dasatinib
Our presenters, Partners Stephen Garner and Anna Gregson, discuss how EPO case law has developed since revocation of the dasatinib patent in 2017, and explore how innovators should adjust their filing and drafting strategy in light of the EPO’s post-dasatinib approach to plausibility.
Watch nowWatch webinar
x
IP for the manufacturing and automotive age of change
Now more than ever, businesses need to be resilient and plan for their future. Businesses must ensure that their IP strategy is aligned with their commercial goals, both to maximise profitability and to mitigate risk. This joint webinar with Hyperdrive, the NEAA and Mathys & Squire Partners Sean Leach and Andrew White, explores how to do this in practice.
Watch nowWatch webinar
x
SPCs in Europe (pt. 2)
Following on from part one, in this webinar Mathys & Squire Partners Peter Arch and Alexander Robinson take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.
Watch now
